Pharma Mar, S.A.

Tweet this page
<
2017
2018
2019
2020
2021
2022
2023
2024
>
Registration as it was on 24 Nov 2017
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

75,000€

Financial year: Jan 2016 - Dec 2016

Lobbyists (Full time equivalent)

0.25 Fte (1)

Lobbyists with EP accreditation

0

High-level Commission meetings

1

Lobbying Costs over the years

  • Info

    Pharma Mar, S.A.   (PharmaMar)

    EU Transparency Register

    840804329063-93 First registered on 22 Nov 2017

    Goals / Remit

    PharmaMar is a company focused on oncology and committed to research and development which takes inspiration from the sea to discover molecules with antitumor activity. We are an integrated company that seeks innovative products to provide healthcare professionals with new tools to treat cancer.

    PharmaMar’s commitment to patients and to research has made it a world leader in the discovery of antitumor drugs of marine origin.

    Main EU files targeted

    Política de investigación
    EMA
    Financiación a la investigación y desarrollo

    Address

    Head Office
    Av. de los Reyes, 1
    Colmenar Viejo
    MADRID 28770
    SPAIN
  • People

    Total lobbyists declared

    1

    Employment timeLobbyists
    25%1

    Lobbyists (Full time equivalent)

    0.25

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    None declared

    Person in charge of EU relations

    Carmen Guijarro (Directora Dpto. Coordinación Proyectos)

    Person with legal responsibility

    JOSE MARIA FERNANDEZ SOUSA-FARO (Presidente)

  • Categories

    Category

    II - In-house lobbyists and trade/business/professional associations

    Subcategory

    Companies & groups

  • Networking

    Affiliation

    EBE
    EFPIA

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jan 2016 - Dec 2016

    Lobbying costs for closed financial year

    75,000€

    EU grant income for closed financial year

    178,747 € (Source: EU Fund)

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    None

    ACC

    None

    Groups (European Parliament)

    None

    Communication activities

    Horizon2020
    Drug Approval procedures

    Other activities

    None declared

  • Meetings

    Meetings

    1 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

    • Date 24 Nov 2017 Location Brussels
      Subject Pharmaceutical policy
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Annika Nowak (Cabinet member)
      • Vytenis Andriukaitis (Commissioner)
      Other Lobbyists
Download this datacard